Henry G. Beetham
710 Cumberland Street
Dunedin, OTA 9016, New Zealand
Dunedin, OTA 9016, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcoma.
Journal: Cancer biology & therapy
Published: November 30, 2025
Involvement of Kindlin-1 in cutaneous squamous cell carcinoma.
Journal: Oncogenesis
Published: December 26, 2023
Discovery of AL-GDa62 as a Potential Synthetic Lethal Lead for the Treatment of Gastric Cancer.
Journal: Journal of medicinal chemistry
Published: December 08, 2021
A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability.
Journal: Cancer research
Published: February 22, 2021
Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors.
Journal: Cancer research
Published: February 07, 2021
E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: June 11, 2018
A Comparison of Real-Time and Endpoint Cell Viability Assays for Improved Synthetic Lethal Drug Validation.
Journal: Journal of biomolecular screening
Published: June 21, 2015
Synthetic Lethal Screens Identify Vulnerabilities in GPCR Signaling and Cytoskeletal Organization in E-Cadherin-Deficient Cells.
Journal: Molecular cancer therapeutics
Published: December 26, 2014
E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition.
Journal: BMC cancer
Published: April 04, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026